Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1-Reference-Cited by-同舟云学术

Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1

Published:2014-11 Issue:21 Volume:24 Page:5086-5088
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Desrat Sandy,Pujals Anaïs,Colas Claire,Dardenne Jérémy,Gény Charlotte,Favre Loëtitia,Dumontet Vincent,Iorga Bogdan I.,Litaudon Marc,Raphaël Martine,Wiels Joëlle,Roussi Fanny

Funder

Fondation de France

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. BCL-2 family antagonists for cancer therapy

2. Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer

3. Bcl-2–family proteins and hematologic malignancies: history and future prospects

4. Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer

5. Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy;International Journal of Biological Macromolecules;2021-09

2. Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL‐1;ChemMedChem;2021-03-23

3. Development of Mcl-1 inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2021-01

4. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer;Cells;2020-05-21

5. Natural disesquiterpenoids: an update;Natural Product Reports;2020